Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients With EGFR Mutant Metastatic Non–small-cell Lung Cancer (NSCLC)
Titel:
Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients With EGFR Mutant Metastatic Non–small-cell Lung Cancer (NSCLC)
Auteur:
Elamin, Yasir Y. Gomez, Daniel R. Antonoff, Mara B. Robichaux, Jacqulyne P. Tran, Hai Shorter, Melissa K. Bohac, Jadi M. Negrao, Marcelo Vailati Le, Xiuning Rinsurogkawong, Waree Lewis, Jeff Lacerda, Lara Roarty, Emily B. Swisher, Stephen G. Roth, Jack A. Zhang, Jianjun Papadimitrakopoulou, Vassiliki Heymach, John V.